News

The once-in-a-decade summit promised to marshall resources that could narrow the estimated $4.3 trillion financing gap needed ...
Summit Therapeutics and AstraZeneca are discussing a partnership deal worth as much as $15 billion, Bloomberg News reported ...
Prime Minister Anthony Albanese has all but ruled out changes to the GST, saying next month’s productivity roundtable should ...
The European Union’s top officials will travel to Moldova’s capital on Friday for a key bilateral summit to strengthen ties ...
President Donald Trump campaigned on keeping the United States out of foreign wars, but it didn’t take long to convince him ...
Summit Therapeutics nears a $15B AstraZeneca deal for ivonescimab, targeting a $90B market. See more on the potential and challenges shaping SMMT's future.
Families packed Legacy Park in Lee’s Summit for a spectacular Fourth of July celebration featuring fireworks, music, ...
Summit Therapeutics (SMMT) stock gains as AstraZeneca (AZN) is said to eye its lung cancer drug ivonescimab, a potential ...
Acting sustainably is no longer a buzzword; it is now a necessity,” were the words of the King’s representative in ...
Event aims to support implementation of Nepal’s Energy Development Roadmap that targets generating an additional 25,000 MW in ...
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.